Table 3.
Variables | Unadjusted HR |
95% CI | p-value | Adjusted HR |
95% CI | p-value |
---|---|---|---|---|---|---|
Recipient age | 1.003 | 0.952–1.057 | 0.902 | 1.006 | 0.947–1.068 | 0.846 |
Donor age | 0.988 | 0.924–1.056 | 0.718 | |||
HLA full matches | 2.037 | 0.394–10.541 | 0.396 | |||
ABO mismatch | 0.554 | 0.066–4.625 | 0.586 | |||
Follow up duration | 0.999 | 0.997–1.001 | 0.332 | 0.999 | 0.997–1.001 | 0.198 |
Gd-IgA1 (units/ng IgA) | 0.881 | 0.644–1.205 | 0.427 | |||
TNFSF 13 (10 ng/mL) | 1.585 | 1.030–2.439 | 0.036 | 1.685 | 1.068–2.658 | 0.025 |
HR: hazard ratio, 95% CI: confidence interval. The hazard ratio was expressed as 1 units of Gd-IgA1/ng IgA increase, 10 ng/mL TNFSF13 increase